Stockwinners Market Radar for August 22, 2024 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

19:50 EDT Xiao-I Corp (ADR) trading halted, news pending

18:47 EDT Fortune Brands Innovations CEO: We love the underlying housing market - In an interview on CNBC's Mad Money, Nicholas Fink said Fortune Brands Innovations has technology that takes cost out of the system. China has been difficult during the past few years, according to Fink, but the team has reoriented the business. The next step for the company in outdoors is to ramp up brand building and innovation, he noted.

18:22 EDT Canadian Pacific Kansas City prepares to restart railway operations in Canada - Canadian Pacific Kansas City said it is preparing to restart railway operations in Canada following the Canadian Minister of Labour's announcement that he will exercise his authority under Section 107 of the Canada Labour Code to direct the Canada Industrial Relations Board to impose final binding arbitration and for railway operations to resume forthwith. CPKC will follow the order of the CIRB once it executes the Minister's direction. Our teams are already preparing for the safe and orderly resumption of our rail network and further details about timing will be provided once we receive the CIRB's order. "The Canadian government has recognized the immense consequences of a railway work stoppage for the Canadian economy, North American supply chains and all Canadians," said Keith Creel, CPKC President and CEO. "The government has acted to protect Canada's national interest. We regret that the government had to intervene because we fundamentally believe in and respect collective bargaining; however, given the stakes for all involved this situation required action." "CPKC looks forward to welcoming all of our employees back to work to restore our railway to full strength and get back to serving our customers and moving Canada's trade and commerce throughout North America," Creel added.

17:30 EDT Brand Engagement promotes Paul Chang to CEO - Brand Engagement Network announced the promotion of Paul Chang to CEO. In his new role, Chang will enable a continuation of operations and execution of the company's ongoing strategy. With Chang's promotion, co-CEO Michael Zacharski will step down from his position with the company.

17:06 EDT Quantum Computing receives noncompliance notice from Nasdaq - Quantum Computing announced that it received a notice from Nasdaq that the company had failed to satisfy a standard for continued listing, Nasdaq Listing Rule 5250, because the company did not timely file its quarterly report on Form 10-Q for the period ended June 30 with the SEC.

17:02 EDT Nintendo to end free-to-play mobile Animal Crossing Pocket Camp - Earlier, Nintendo posted in part: "Animal Crossing: Pocket Camp Notice Regarding the End of Service. "Nintendo has announced plans to shut down Animal Crossing: Pocket Camp...Online service for Animal Crossing: Pocket Camp will end on November 29th, 2024 at 12:00 AM. Since service began on November 21st 2017, for approximately seven years we have been honored to see everyone's lovely, diverse campsites grow and flourish. We extend our heartfelt thanks to the many users who have loved Animal Crossing: Pocket Camp. After service ends, you will no longer be able to play Animal Crossing: Pocket Camp....Note that we are currently developing a paid version of the app to which you will be able to transfer your save data. It will be released during the same period as the end of service for Animal Crossing: Pocket Camp," the company said in part. Reference Link

16:54 EDT Evercore CFO LaLonde sells 3,750 class A shares - In a regulatory filing, Evercore CFO Timothy Gilbert LaLonde disclosed the sale of 3,750 class A common shares of the company on August 21 at a price of $238.7234 per share.

16:38 EDT Vision Sensing Acquisition, Mediforum terminate merger agreement - Vision Sensing Acquisition has mutually agreed with Mediforum to terminate the agreement and plan of merger dated as of January 12. The parties agreed that it would not be possible for them to complete the proposed transaction within a reasonable period of time and have waived any claims against each other. Concurrently, VSAC is pleased to announce that it has entered into a non-binding letter of intent with Delaware incorporated Convergence CT to complete a business combination between the company and CCT pursuant to which VSAC will directly or indirectly acquire 100% of the outstanding equity of the company in exchange for the consideration described below. The legal transaction structure will be determined by the parties based on business, legal, tax, accounting, and other considerations.

16:32 EDT International Game signs ticket printing contract with Portugal's lottery - International Game subsidiary IGT Global Solutions has signed a three-year primary instant ticket printing and related services contract with longtime partner Santa Casa da Misericordia de Lisboa, Portugal's national lottery. The contract was awarded following a competitive procurement. SCML will have access to IGT's instant ticket content and innovations portfolio, including top-performing games. IGT will also provide SCML with marketing services including game development and analytics. IGT has been the primary lottery technology partner to SCML since 2000, and delivers retail central system hardware, software, terminal maintenance and field services to the Lottery.

16:30 EDT Hancock Whitney chief legal officer Phillips to retire - Hancock Whitney Senior Executive Vice President and Chief Legal Officer Joy Lambert Phillips recently announced she will retire from the company on September 6, 2024. "Joy Phillips has been invaluable to our organization's growth for more than 25 years, championing the highest standards of legal ethics and corporate governance according to core values our founders set forth 125 years ago," said Hancock Whitney President and Chief Executive Officer John M. Hairston. "As she starts this new chapter in life, she leaves in her stead a highly accomplished, highly capable successor, Nita Kuhner, as General Counsel and Corporate Secretary as well as a team of very talented attorneys, legal professionals, and corporate governance specialists who help ensure legal and regulatory compliance across all areas of company operations."

16:18 EDT Stifel Financial reports July total client assets $481.52B - Stifel Financial reported selected operating results for July 31. Reports July fee-based client assets $183.42B. Reports July private client group fee-based client assets $160.53B. Reports July bank loans $20.27B. Reports July client money market and insured product $24.3B.

16:16 EDT Fresh2 Group receives added delinquency compliance notice from Nasdaq - Fresh2 Group announced that on August 19 it received an additional delinquency compliance alert notice from the Listing Qualifications Department of The Nasdaq Stock Market advising they have not received the Company's Form 10-Q for the period ended June 30 it does not comply with the Listing Rules 5250(c)(1) which requires the timely filing of all required periodic reports with the SEC.Previously, Nasdaq Staff had granted the Company an exception until September 27 to file its delinquent Form 10-K for the period ended December 31, 2023...

16:13 EDT Parsons awarded $46M to oversee operations at strategic transportation customer - Parsons Corporation announced that the company has been awarded nearly $46M to oversee Operations Technology Maintenance Services for an East Coast strategic transportation customer. "We are proud to apply our cutting-edge technologies to improve service delivery," said Mark Fialkowski, president of Infrastructure North America for Parsons. "As leaders in digital transformation, our capabilities will enhance and streamline our program management delivery model, providing premier transportation technology services and solutions."

16:10 EDT Uber, Cruise to deploy autonomous vehicles on Uber platform - Uber Technologies (UBER) and General Motors' (GM) Cruise announced a multiyear strategic partnership to bring Cruise autonomous vehicles to the Uber platform. The companies plan to launch the partnership next year with a dedicated number of Chevy Bolt-based autonomous vehicles. Once launched, when an Uber rider requests a qualifying ride on the Uber app, they may be presented with the option to have that trip fulfilled by a Cruise autonomous vehicle. "Cruise is on a mission to leverage driverless technology to create safer streets and redefine urban life," said Marc Whitten, CEO of Cruise. "We are excited to partner with Uber to bring the benefits of safe, reliable, autonomous driving to even more people, unlocking a new era of urban mobility."

16:07 EDT Jazz Pharmaceuticals updates Phase 3 trial of cannabidiol oral solution - Jazz Pharmaceuticals announced top-line results from the Phase 3 open-label, single-arm trial in Japan evaluating the safety and efficacy of cannabidiol oral solution as an adjunctive treatment for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome or tuberous sclerosis complex. The trial did not meet the primary efficacy endpoint of a pre-specified percentage change in indication-associated seizure frequency during the treatment period compared to baseline in Japanese pediatric patients; however, numeric improvements were observed in the primary and several secondary endpoints. No new safety signals were observed in the trial. "We are confident in the overall clinical profile of Epidyolex, which has been established in five Phase 3 clinical trials in more than 900 patients. We believe the totality of the Epidyolex global data, including the findings from this trial, supports advancement of the program in Japan," said Rob Iannone, M.D., M.S.C.E., executive vice president, global head of research and development of Jazz Pharmaceuticals. "We are continuing to collect data in Japanese patients and plan to engage with regulatory authorities in Japan regarding a potential new drug application (JNDA). We recognize the significant unmet need for patients in Japan living with rare epilepsies and thank the investigators, patients and caregivers who are involved in this trial."

16:04 EDT Workday reports Q2 subscription revenue $1.903B, up 17.2% y/y

16:03 EDT Workday adopts Equifax-s employment and income verification services - Workday (WDAY) and Equifax (EFX) announced a new strategic partnership to help make employment and income verifications for Workday customers' employees easier. By integrating Workday Payroll and The Work Number employment and income verification service from Equifax, Workday customers will be able to offer their employees instant verifications in support of events such as buying their first home. Workday's new opt-in Employment Verification Connector For Equifax integration is expected to be available to all U.S. Payroll customers in 2025. Workday is providing this integration at no additional cost to customers.

15:59 EDT Symbotic down 11% in late day trading - Sources have pointed to a critical report shared by a journalist Bethany McLean as a potential contributor to the weakness in the shares. Symbotic shares are down $2.68, or 11%, at $22.19 heading into the close. Reference Link

15:22 EDT Toll Brothers Selling move-in-ready homes at Highlands at Vinings in Atlanta - Toll Brothers is now offering a limited number of quick move-in and move-in ready homes at Highlands at Vinings, a luxury new home community featuring four-story townhomes with private elevators in each residence and sought-after rooftop terraces in Atlanta, Georgia. "The community is located at 2741 Wynberry Lane in the vibrant downtown Vinings area of Atlanta. Brand new, move-in ready townhomes in the community are now available starting at $925,000...One of the move-in ready townhomes that has just been put on the market for sale is a stunning Chastain Transitional home design priced at $945,000. This open-concept, end-unit townhome features an expansive great room overlooking a spacious kitchen with ample cabinet and countertop space, as well as multi-stacking doors leading to a desirable covered deck. Tucked away on the fourth floor, an additional bedroom with a walk-in closet and shared hall bath overlooks a generous loft that opens with multi-stacking doors to a spacious rooftop terrace that is partially covered," the company noted...

14:25 EDT Pfizer, BioNTech confirm FDA approval for updated COVID-19 vaccine - Pfizer (PFE) and BioNTech SE (BNTX) announced that the Food and Drug Administration has approved the supplemental Biologics License Application for individuals 12 years of age and older for Comirnaty vaccine, mRNA, and granted emergency use authorization for individuals 6 months through 11 years of age of the companies' Omicron KP.2-adapted 2024-2025 Formula COVID-19 vaccine. "This season's vaccine is for use as a single dose for most individuals 5 years of age and older. Individuals 5 years of age and older with certain kinds of immunocompromise previously vaccinated with Pfizer and BioNTech COVID-19 vaccines or children under the age of 5 who have not already completed a three-dose series with previous formulas of a COVID-19 vaccine may be eligible to receive additional doses. The KP.2 adaptation is based on guidance from the FDA, which stated that KP.2 is the preferred strain of the JN.1 lineage for COVID-19 vaccines for use in the U.S. during the 2024-2025 fall and winter season, if feasible. Staying up to date on vaccinations in line with the Centers for Disease Control and Prevention recommendations remains important, particularly in light of COVID-19 cases on the rise again. This season's Pfizer and BioNTech COVID-19 vaccine will begin shipping immediately and be available in pharmacies, hospitals, and clinics across the U.S. beginning in the coming days," the companies stated.

14:04 EDT MoneyHero announces non-binding offer to acquire MoneySmart - MoneyHero announced that it has made a non-binding offer to acquire 100% of the shares of MoneySmart, the second largest player in the personal finance and digital insurance aggregation and comparison market in Greater Southeast Asia. "This strategic move aims to consolidate MoneyHero's leading position and unlock significant synergies in Asia's rapidly evolving personal finance and insurance landscape. Under the terms of the offer, MoneyHero has valued MoneySmart at US$8.0 million with potential valuation upside. The US$8.0 million consideration is to be paid in new MoneyHero shares whereas the potential additional valuation upside will be paid in cash contingent on the results of a thorough due diligence process. While MoneyHero's intent is to acquire 100% of MoneySmart, the Company is also exploring the purchase of any number of shares from individual shareholders. The consideration of US$8.0 million in MNY shares and an additional cash amount (to be defined based on due diligence results) references MoneySmart's recent capital reduction reflected in recent filings made with the Accounting and Corporate Regulatory Authority of Singapore. MoneyHero's offer reflects a premium for MoneySmart's business, as well as confidence in the value that MoneySmart would bring to the combined entity," the company stated. "Our offer to MoneySmart reflects the strategic value of combining our two companies," said Rohith Murthy, CEO of MoneyHero. "This acquisition will further strengthen our leadership in Greater Southeast Asia, delivering enhanced products, services, and technological innovation. Given MoneySmart's recent share buyback, we believe we've made a fair and compelling offer that benefits both sides. Most importantly, we believe the synergies from this merger will drive significant value for our shareholders and customers."

13:45 EDT Bayer initiates Phase II study of sGC activator in chronic kidney disease - Bayer announced the start of ALPINE-1 study, a Phase II clinical trial with BAY3283142, an investigational soluble guanylate cyclase, or sGC, activator, in patients with chronic kidney disease. The results of this study have the potential to provide evidence of the sGC activator as a viable treatment option for cardiovascular diseases. "This study marks a significant step forward in our commitment to addressing the high unmet medical need in this patient population and advancing our innovative approach to treat renal disease," said Christian Rommel, Head of Research and Development at Bayer's Pharmaceuticals Division. "In addition, this further strengthens our overall development portfolio. We are dedicated to advancing the development of BAY3283142 to improve outcomes for patients with chronic kidney disease and related cardiovascular conditions." Following the successful first-in-human trials, the goal of the randomized, double-blind, placebo-controlled, multi-center Phase II ALPINE-1 study is to assess the efficacy and safety of BAY3283142 in patients with chronic kidney disease. BAY3283142 is a sGC activator that represents an innovative approach to modulating the nitric oxide-sGC-cyclic guanosine monophosphate pathway with a broad treatment potential in cardiovascular diseases.

13:35 EDT Tesla Finance VP Sreela Venkataratnam to exit company - Tesla Finance VP Sreela Venkataratnam announced in a post on LinkedIn that she is leaving the company after 11 years. Venkataratnam praised Tesla but said working there was "not for the faint of heart." "Leaving as a Vice President (one of only two women VPs in the company) with annual revenues soaring close to $100B, market cap to $700B (reaching $1T during the pandemic) and cars delivered in a year to more than 1.8 million, I am proud of how much we've achieved together," Venkataratnam wrote. Reference Link

13:25 EDT Evolent jumps 12% to $31.47 after Reuters says in sale talks

13:02 EDT Holdco Nuvo Group DG Ltd trading halted, news pending

12:40 EDT Air Canada pilots represented by ALPA union vote to authorize strike - Air Canada pilots, represented by the Air Line Pilots Association voted overwhelmingly in favour to authorize union leaders to call a strike. With 98% of members participating, 98% of Air Canada pilots voted in favour of job action, if necessary, to achieve a new contractual agreement with Air Canada. Air Canada pilots are working under pay rates and quality-of-life provisions negotiated in 2014. Negotiations for a new agreement began in June 2023. Talks entered private mediation in January 2024 and lasted until June 2024, at which point the union decided to file a notice of dispute and enter conciliation because the two sides were unable to reach a new collective agreement. "Today, more than 5,400 Air Canada pilots sent a clear message to management that we are willing to go the distance to secure a contract that reflects the value we bring to Air Canada," said First Officer Charlene Hudy, chair of the Air Canada ALPA Master Executive Council. "Our goal is to avoid a strike, and our focus remains on modernizing our contract for Air Canada pilots. However, management continues to force us closer to a strike position by not listening to our needs at the negotiating table regarding fair compensation, respectable retirement benefits, and quality-of-life improvements. After more than a year of negotiations, management must now to come to the realization that if they fail to reach an agreement, they will be responsible for us withdrawing our services."

12:09 EDT Saba Capital comments on Neuberger Berman Funds' 2024 joint annual meeting - Saba Capital Management, L.P., the largest shareholder of the Neuberger Berman Municipal Fund (NBH) and the Neuberger Berman Next Generation Connectivity Fund (NBXG), commented on the rigged election Neuberger Berman held at the Funds' 2024 Joint Annual Meeting of Shareholders. Based on the preliminary results of the Annual Meeting, shareholders overwhelmingly voted to elect Saba's director candidate, Paul Kazarian, to the Funds' Boards of Directors. However, due to Neuberger Berman's majority vote standard, Mr. Kazarian will not be granted his seat and Neuberger Berman's incumbent directors will hold onto their seats despite failing to receive a majority of the votes cast. Boaz Weinstein, Founder and Chief Investment Officer of Saba, commented: "Despite the clear mandate for change from NBH and NBXG shareholders, Neuberger Berman's impossible-to-achieve vote standard allows its directors to hold onto their seats in perpetuity - even when they lose an election. Directors who are responsible for deplorable shareholder returns and excessive discounts to NAV should not be permitted to continue serving on the board of any closed-end fund, especially when shareholders resoundingly reject them as they have at these two funds. Shame on Neuberger Berman for running a rigged election that allows incumbent directors who lose by a huge landslide to keep their seats... This rigged election has occurred at a time when closed-end fund shareholder rights are under attack on several fronts. Right now, managers such as Neuberger Berman and their lobbyists are attempting to push through proposals at the NYSE and CBOE to eliminate closed-end fund shareholders' right to annual elections. Saba and countless other investors, governance experts and independent academics find it appalling that these bad actors are attempting to eliminate one of shareholders' most fundamental rights just so that their hand-picked directors can serve unchecked for life, without any recourse for ordinary investors. It is imperative that shareholders' voices are heard and acknowledged - not silenced. This is why Saba continues to do everything in its power to protect the rights of closed-end fund shareholders."

12:00 EDT Snowflake falls -13.7% - Snowflake is down -13.7%, or -$18.45 to $116.61.

12:00 EDT Advance Auto Parts falls -16.3% - Advance Auto Parts is down -16.3%, or -$10.07 to $51.84.

12:00 EDT Trinseo rises 10.4% - Trinseo is up 10.4%, or 35c to $3.73.

11:07 EDT United Bancorp raises quarterly dividend to 17.75c per share - On August 21, 2024, the Board of Directors of United Bancorp declared a third quarter dividend payment of 17.75c per share for shareholders of record on September 10, 2024 with a payment date of September 20, 2024. This is an increase of 1c, or 6%, over the regular cash dividend paid in the third quarter of the previous year. In addition, this payment is greater than the regular cash dividends paid in the first and second quarters of the current year, which were 17.25c and 17.5c respectively. At the third quarter payment level, the regular cash dividend produces a forward yield of 5.7% based on UBCP's market value of $12.55 at the most recent quarter-end.

10:05 EDT GXO Logistics enters long-term contract renewal with Affinity Petcare - GXO Logistics announced a long-term contract renewal with animal nutrition leader Affinity Petcare. To support Affinity Petcare's growth, GXO operates 24,000 square meters of space in its site near Blois, where the GXO team manages over 500,000 pallets per year. As part of its commitment to continuous improvement, GXO will implement several innovations on site to increase productivity and flexibility. GXO manages logistics for raw materials, product preparation and delivery of Affinity Petcare products.

10:00 EDT DRDGold falls -8.5% - DRDGold is down -8.5%, or -82c to $8.86.

10:00 EDT Advance Auto Parts falls -17.8% - Advance Auto Parts is down -17.8%, or -$11.04 to $50.88.

10:00 EDT Beachbody Company rises 7.3% - Beachbody Company is up 7.3%, or 50c to $7.36.

09:48 EDT Snowflake falls -10.3% - Snowflake is down -10.3%, or -$13.87 to $121.19.

09:48 EDT Advance Auto Parts falls -20.6% - Advance Auto Parts is down -20.6%, or -$12.72 to $49.20.

09:48 EDT Unifi rises 7.9% - Unifi is up 7.9%, or 46c to $6.31.

09:32 EDT Vontier's Gilbarco Veeder-Root secures $59M HPCL tenders - Vontier Corporation announced that Gilbarco Veeder-Root, a Vontier company, has secured two tenders worth a combined $59M from Hindustan Petroleum Corporation Ltd. The tenders include $39M for above-ground dispensers combined with eight years of service support, and $20M for underground submersible turbine pumps, to be delivered across HPCL's retail outlets throughout India over the next 18 months. "We are proud to partner with HPCL to support India's strong growth and its ambitious infrastructure, modernization and decarbonization goals," said Viswanath Devarajan, Managing Director, Gilbarco Veeder-Root India. Under the agreement, Gilbarco Veeder-Root will provide critical products and services to support India's growing road network and infrastructure, which has expanded by nearly 60% in only nine years. The country's 2030 decarbonization goal and COP26 commitments include decarbonizing energy to 50% and achieving 500 GW of fossil fuel-free generating capacity by 2030.

09:26 EDT Nisun International announces increased ownership by largest shareholder - Nisun International's largest shareholder, Bodang Liu, has increased his ownership in the company through open market purchases. On August 8, 9 and 19, Liu purchased an additional 102,700 shares at an average price of $9.73 per share, investing approximately $999,156 in total. This purchase increased Liu's ownership from 19.36% to 21.92% of the outstanding shares.

09:22 EDT FuelCell announces C$5.9M grant from Natural Resources Canada's CFF - FuelCell Energy announced that a C$5.9 million grant from Natural Resources Canada's Clean Fuels Fund will finance two projects utilizing its electrolyzer technology to produce synthetic fuel or "eFuel." These projects are being carried out with Canadian Nuclear Laboratories, Expander Energy Inc., Nuclear Promise X, and St. Marys Cement and are focused on producing low-carbon-intensity synthetic diesel fuels using zero-carbon hydrogen that will be produced by leveraging nuclear power, and FuelCell Energy's Solid Oxide electrolysis platform.

09:17 EDT Globavend announces notice of non-compliance from Nasdaq - Globavend Holdings received a notice from the Nasdaq Stock Market that GVH is not currently in compliance with the $1.00 minimum bid price requirement for continued listing of the Company's ordinary shares on the Nasdaq Capital Market, as set forth in Nasdaq Listing Rules. The Notice indicated that the Company has 180 days, or until February 12, 2025, to regain compliance with the Minimum Bid Price Requirement by having the closing bid price of the Ordinary Shares meet or exceed $1.00 per Ordinary Share for at least ten consecutive business days. The Notice has no immediate effect on the listing of the Company's Ordinary Shares, which continue to trade on The Nasdaq Capital Market under the symbol "GVH." The Company intends to monitor the closing bid price of its Ordinary Shares and may, if appropriate, consider implementing available options to regain compliance with the Minimum Bid Price Requirement, including a reverse stock split.

09:16 EDT Jamf Holding joins Okta's Elevate Partner Program - Jamf (JAMF) has joined the Okta (OKTA) Elevate Partner Program to drive further go-to-market alignment and accelerate product innovation between the companies.

09:12 EDT Sealsq supports telcos in accelerating adoption of eSIM specifications - SEALSQ is actively supporting the growing adoption of eSIM specifications and remote SIM provisioning within the telecommunications industry, ensuring greater interoperability between devices and promoting a security-by-design approach. This will ultimately lead to a more efficient and secure experience for consumers, fully aligning with SEALSQ's mission to build a safer connected world. The eSIM, also known as the embedded Subscriber Identity Module, is a digital SIM card seamlessly integrated into mobile devices such as smartphones or tablets. Unlike traditional physical SIM cards that can be detached and replaced, an eSIM is embedded into the device's hardware and can be programmed with multiple mobile network profiles. This allows users to switch carriers and easily start or change mobile plans without needing to replace a physical SIM card. The explosive growth of IoT-connected devices in consumer electronics and M2Mapplications is driving this market expansion. In 2021, the adoption of eSIM technology accelerated significantly, with an increase in the frequency of eSIM profile downloads on consumer devices. Commercial eSIM services for smartphones have now been established in at least 69 countries worldwide, marking a threefold increase compared to 2020. The eSIM also holds immense potential in the automotive industry, where it is expected to open up new growth opportunities.

09:11 EDT PharmAla appoints William Avery as CFO - PharmAla Biotech will be engaging Mr. William Avery, CPA, CA, as CFO for the Corporation, effective October 1st. Mr. Avery has been acting as Financial advisor for PharmAla Biotech for over a month. Mr. Avery is a former partner at MNP, focusing on publicly traded companies in innovative fields. The Board of PharmAla Biotech extends their thanks to Mr. Carmelo Marelli, the company's outgoing CFO, for his years of service.

09:08 EDT MGO Global, Heidma submit draft registration statement for combination - MGO Global and Heidmar jointly announced the confidential submission with the U.S. Securities and Exchange Commission of a draft registration statement on Form F-4 by Heidmar Maritime Holdings Corp., a newly created holding company organized under the laws of the Republic of the Marshall Islands. As previously announced on June 20, 2024, MGO entered into a Business Combination Agreement on June 18, 2024 with Heidmar; Holdings; HMR Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Holdings and Rhea Marine Ltd. and Maistros Shipinvest,whereby MGO and Heidmar will become wholly owned subsidiaries of Pubco. The closing of the transactions contemplated by the BCA is subject to certain conditions, including, without limitation, the approval of MGO's stockholders and Nasdaq's approval of the listing of the ordinary shares of Pubco on the Nasdaq Stock Market.

09:06 EDT Westhaven Gold expands claim package at Shovelnose Gold property - Westhaven Gold has entered into a strategic transaction with Talisker Resources which will, together with additional staking completed by Westhaven, expand the Shovelnose gold property by 24,000 hectares to 41,623 hectares . The Shovelnose is located within the prospective Spences Bridge Gold Belt, which borders the Coquihalla Highway 30 kilometres south of Merritt, B.C. Westhaven entered into a property purchase agreement dated August 19, 2024 with Talisker to acquire 12 claims covering 23,550 hectares contiguous with its Shovelnose gold property. Westhaven has staked an additional 450 hectares. Westhaven has increased its exposure to this emerging epithermal gold district; Spences Bridge Gold Belt. Exploration by Westhaven has highlighted a corridor that hosts South Zone, FMN and Franz, extends for over 11km and trends into these claims to the southeast. The southeast extent of this corridor is highly prospective, containing anomalous epithermal pathfinders; antimony and mercury, and the recently discovered Certes showing, where banded mercury-bearing, high level epithermal quartz has been identified. The Certes showing and the southeast extent of the corridor has not been drill tested. The presence of high-level quartz veins and anomalous Sb-Hg geochemistry, suggests that the southeast extent of the Shovelnose epithermal corridor is more preserved, raising the potential for additional discoveries within this area. Pursuant to the Agreement, Westhaven will acquire the Claims from Talisker by paying $20,000 in cash, granting a 1% Net Smelter Royalty on the Claims and issuing an aggregate of 1,500,000 common shares of the Company. The shares will be subject to contractual restrictions to be released in equal installments at 4 months, 8 months and 12 months from the date of issue. Westhaven will have the option to buyback the 1% NSR at anytime for $1,000,000. The transaction remains subject to satisfaction of closing conditions customary for transactions of this nature as well as TSX Venture Exchange approval

09:06 EDT IGC Pharma: Research shows new molecule IGC-1C targets tau protein in AD - IGC Pharma announced preclinical research demonstrating the therapeutic potential of IGC-1C, a novel small-molecule modulator. The findings show that IGC-1C targets tau protein phase separation, presenting new opportunities for addressing multiple pathways in neurodegenerative disease. Additionally, the Company previously announced that IGC-1C along with IGC-1A have been identified by the Company's Artificial Intelligence model as potential GLP-1 receptor agonists, offering promise as candidates for weight loss treatments and presenting a unique strategy to combat Alzheimer's disease..."Our discovery of IGC-1C's potential dual action, targeting both tau and GLP-1 receptors, marks a significant advancement in our Alzheimer's disease research and treatment," said Ram Mukunda, CEO of IGC Pharma. In addition to its impact on tau pathology, IGC-1C has been identified as a potential GLP-1 receptor agonist. GLP-1 is a hormone with receptors throughout the brain, including areas affected by Alzheimer's. Research indicates that GLP-1 has been shown to be neuroprotective against Ass toxicity by reducing oxidative stress and inflammation, increasing Ass clearance, improving insulin signaling, and promoting neurogenesis. This dual mechanism positions IGC-1C as a promising candidate for treating weight loss, and neurodegenerative and metabolic disorders, although there can be no assurance thereof.

09:05 EDT Edible Garden announces new partnership with University of Rhode Island - Edible Garden AG announced a new partnership with the University of Rhode Island as part of a graduate research project focused on sustainability in the CEA greenhouse sector. This collaboration will involve Edible Garden opening its production facility to University researchers, who will evaluate the company's current sustainability initiatives. "We are proud to partner with the University of Rhode Island on this important initiative," said Jim Kras, CEO of Edible Garden. "This collaboration represents a significant step forward in our mission to continuously improve our sustainability practices. By participating in this comprehensive assessment, we are not only benchmarking our efforts against industry standards but also gaining valuable insights that will help us set clear, actionable goals to elevate our sustainability initiatives. Additionally, beyond enhancing our internal operations, we see this project as an opportunity to contribute to the broader conversation about the environmental impact of the greenhouse CEA industry. As stewards of the planet, it is essential that we share our findings to drive positive change within the industry."

09:04 EDT Tevogen secures $6M Series C Preferred Stock Investment - Tevogen Bio has entered into a definitive agreement for a $6.0 million Series C Preferred Stock investment with The Patel Family, LLP. The shares of Series C Preferred Stock will have a 7.5% dividend per year, accruing and payable quarterly. The Series C Preferred Stock is convertible into shares of common stock after 6 months at the election of the holder, and callable by Tevogen for redemption after 5 years at Tevogen's election. The Series C Preferred Stock does not have any mandatory redemption and is non-voting. Dividends will cease to accrue after 10 years if the Series C Preferred Stock remains outstanding at that time. The purchase agreement for the Series C Preferred Stock provides for two closings, one on August 30, 2024, for $4.0 million, and one on September 16, 2024, for $2.0 million.

09:02 EDT Clover Health appoints Tran to board of directors, Audit Committee - Clover Health Investments announced it has appointed Thomas Tran to the Company's Board of Directors, and as a member of the Audit Committee. Most recently, from February 2022 to June 2023, Tran served as chief financial officer and as a director of Upstream Care

09:01 EDT Ageagle Aerial Systems provides update on sensor sales - AgEagle Aerial Systems announces the Company has sold $833,610 of sensors and sensor-related accessories through its vast network of Value Added Resellers, VAR, from July 1, 2024 to Aug 15, 2024. The Company closed sales of 87 sensors, including RedEdge-P, Altum-Pt and RedEdge-p Dual sensors and a variety of accessories. Bill Irby, AgEagle President, stated, "We are grateful for the accretive growth achieved through our trusted VAR network as the Company achieves another notable sales milestone. Our best-in-class multispectral, panchromatic and thermal sensors are now integrated in over 150 different drones worldwide and distributed in over 70 countries. As our sensor products continue to fulfill the diverse needs of our commercial and government customers, we look forward to pursuing growth across our entire product line to best position the company for long-term shareholder value."

08:54 EDT Mawson Infrastructure reports July revenue $3.94M - Overall monthly revenue of about $3.94 million, monthly digital asset colocation business revenue up 54% Y/Y to $2.75 million, monthly energy management business revenue of $0.75 million, monthly Bitcoin self mining business revenue of $0.44 million, and recently expanded into AI and HPC Markets. Rahul Mewawalla, CEO and President, stated, "We are pleased to deliver another month of significant progress across several key areas that are expected to contribute to future growth opportunities for our digital infrastructure platforms, including delivering 54% year-over-year growth in our digital assets colocation revenue. We also have been ramping up our recent digital assets enterprise colocation customer deployment post the 20 MW expansion, which has grown our current operational capacities at our Midland Facility to 120MW, and increased our overall current operating capacity to 129MW. In addition, we have expanded our digital colocation business into new digital assets with this ramp up of our latest customer deployment. Moreover, the recent expansion of our business into AI and HPC colocation services marks a significant step forward in our long-term growth strategy. This expansion not only broadens our revenue streams but also positions Mawson as a rising player in the AI and HPC infrastructure space, while expanding our growth and innovation initiatives, as we continue to position ourselves strategically in the overall digital infrastructure space."

08:43 EDT HUB Security formalizes collaboration with Blackswan Technologies - HUB Cyber Security announced the formalization of the terms of its collaboration with Blackswan Technologies. Following a successful phase of collaboration, HUB Security and BST are advancing their partnership to co-develop and showcase innovative SDF solutions. As part of the agreement between the parties, HUB Security has the exclusive option to acquire BST by August 22, 2025, subject to adjustment and further terms and conditions that would be set forth in a definitive agreement. The SDF solution integrates BST's unique data fabric architecture with the Company's security systems, significantly enhancing overall security capabilities. This integration is designed to reduce the cost of data management and security for large financial institutions and government entities by over 30%, thanks to the elimination of costly ETL and unnecessary data-lake expenses.

08:37 EDT Heico acquires Capewell's Aerial Delivery, Descent Devices divisions - HEICO announced its Flight Support Group has acquired the Aerial Delivery and Descent Devices divisions of Capewell Aerial Systems for cash at closing. Additional financial details were not disclosed. HEICO stated that it expects the acquisition to be accretive to its earnings within the year following closing. Connecticut-based Capewell is a leading provider of proprietary aircraft cockpit emergency egress and aerial delivery products for various commercial aerospace and defense uses. It is a critical supplier to a wide-ranging customer base that includes leading OEMs, end-users, and distributors. Capewell's highly engineered product portfolio encompasses emergency descent devices, personnel and cargo parachute products, heavy airdrop platforms, and other highly-engineered products. The Survivability division of Capewell will be retained by Argosy Private Equity of Wayne, PA, under the Aerial Machine & Tool Corp brand. Capewell adds additional products and capabilities to HEICO's rapidly-growing and highly-successful Specialty Products Group operations which are dedicated to manufacturing high-reliability, mission-critical components for primarily aerospace and defense customers.

08:35 EDT Brightline Interactive expands partnership with GSI for VR training - The Glimpse Group announced that its subsidiary company Brightline Interactive has received a mid six figure dollar contract modification from a top government systems integrator to continue providing VR training to a key U.S. government agency with over 45,000 employees. In partnership with the GSI, which is a Fortune 500 defense, aviation, information technology, and biomedical research company, BLI has supported the Customer since July 2021, bringing expertise in immersive training, and VR development. Brightline's interactive digital twin environment, presented in VR, features an exact replica of an electrical facility with specific agency equipment rendered in photorealistic detail. The hands-on interactions built into the VR training allow engineers to learn and understand complex systems without the risk of real-world consequences, enhancing skill acquisition, reducing training costs, and minimizing downtime. In addition, BLI is working with the Customer to build an enterprise immersive platform that will deliver VR training and other spatial and 3D content across their agency.

08:33 EDT ConnectM publishes new investor presentation - ConnectM Technology Solutions, published its investor presentation to the Company's investor relations website. The Company's investor presentation has also been filed with the Securities and Exchange Commission. The investor presentation highlights ConnectM as an asset light and capital efficient business formed from its technology platform, the Energy Intelligence Network, which demonstrates the ability to electrify homes, businesses and transportation with clean energy to capture its large addressable market of $2 trillion in the United States residential and commercial energy expenditure. Additionally, the AI powered Energy Intelligence Network streamlines the Company's business verticals including all-electric equipment installation, repair and services and provides automation of distributors and service providers for maximum customer LTV realization relative to the OEM partnerships.

08:32 EDT Star Equity adopts Rights Agreement to protect net operating losses - Star Equity Holdings Board of Directors has adopted, and the Company has entered into, a Rights Agreement with Equiniti Trust Company, LLC, as rights agent, designed to preserve the value of the Company's significant U.S. net operating loss carryforwards and other tax benefits. Star Equity intends to seek stockholder approval of the Rights Agreement at its 2024 annual meeting of stockholders, although the Rights Agreement is effective immediately. Star Equity had U.S. federal income tax NOLs of approximately $43.2 million as of December 31, 2023. The Company believes that in light of the significant amount of its NOLs, it is advisable to adopt the Rights Agreement. Section 382 of the Internal Revenue Code generally allows a company to use NOLs to offset future taxable income and therefore reduce federal income tax obligations. However, the Company's ability to use its NOLs could be substantially limited if there is an "ownership change" under Section 382. In general, an ownership change would occur if stockholders viewed under Section 382 as owning 5% or more of the Company's common stock increase their collective ownership by more than 50 percentage points over a defined period of time. The Rights Agreement and the rights issued under the Rights Agreement will expire on August 8, 2027, or on an earlier date if certain events occur, as described more fully in the Rights Agreement.

08:31 EDT Tomi Environmental Solutions expands partnership with leader in lab services - TOMI Environmental Solutions announced the expansion of its partnership with a global leader in laboratory testing and diagnostics services with multiple mobile equipment purchases and a Custom Engineered System to support the expansion of their Wisconsin facility. The client initially became a customer of TOMI in 2021 and recently purchased additional equipment to support cell gene therapy at its Wisconsin facility. The order of $715,000 includes two mobile Environment Systems and a seven-applicator iHP CES system for three decontamination rooms.

08:15 EDT SciSparc says MitoCareX appoints Nir Peled to Scientific Advisory Board - SciSparc announced that MitoCareX Bio has appointed Professor Nir Peled as a member of its scientific advisory board. Professor Peled is a distinguished expert in thoracic oncology, holding board certifications in internal medicine, pulmonology, and medical oncology. His extensive contributions to the field are well-recognized, having served as a board member of the International Association for the Study of Lung Cancer and currently the chair of the Global Multidisciplinary Practice Standards Committee, as well as past Chair of the IASLC's Screening & Early Detection Committee. Additionally, he recently concluded his term as the Chair of the Thoracic Cancer Assembly of the European Thoracic Society.

08:06 EDT Oblong announces reverse stock split by a ratio of 1-for-40 - Oblong announced that it has filed an amendment to its certificate of incorporation that will effect a reverse stock split of the Company's issued and outstanding shares of common stock by a ratio of 1-for-40, as approved by the Company's stockholders at its 2023 annual meeting and the Company's board of directors. The reverse stock split will become effective at 5:00 PM Eastern Time on August 23, 2024, and the Company's shares of common stock will begin trading on a split-adjusted basis on the Nasdaq Capital Market at the commencement of trading on August 26, 2024 under the Company's existing trading symbol "OBLG."

08:06 EDT Worksport publishes investor Q&A responses - Worksport shared answers to key investor questions submitted through its recently launched Investor Q&A Portal and during its Q2 earnings call. This initiative further strengthens Worksport's open communication efforts as the Company continues its growth trajectory. Worksport's Q2 Earnings Call occurred at 4:30 PM ET on Tuesday, August 13, 2024, where the Company reported record-high revenues. YAnswers To Investor Questions: The Company addresses key investor questions, categorized into three segments: A) Company & Financial Questions, B) Worksport Automotive Accessories Questions, and C) Worksport Clean-Tech Questions.

08:05 EDT SolarBank to develop 6.41 MW community solar power project in New York state - SolarBank intends to develop a 6.41 MW DC ground-mount solar power project known as the East Bloomfield project in East Bloomfield, New York. The Project is expected to be eligible for incentives under the New York State Energy Research and Development Authority - NYSERDA - NY-Sun Program. The company has secured a lease over the Project site, received interconnection approval for the Project, and has received a Special Use Permit for the Project from the Town of East Bloomfield. Once completed, the Project will be operated as a community solar project, as a group of solar panels with access to the local electricity grid. By subscribing to a project, a homeowner earns credits on their electric bill every month from their portion of the solar that's generated by the project, accessing the benefits of solar without installing panels on their home.

08:05 EDT Deutsche Bank settles with 60% of claimants in Postbank case - Deutsche Bank announced that it has made "significant" progress in its conversations with plaintiffs in the litigation concerning the takeover of Postbank and the offer price paid to former Postbank shareholders. The bank has reached agreements with more than 80 plaintiffs representing almost 60% of the total claims in this litigation, settling on the basis of 31 euros per share as proposed by the bank. Among the plaintiffs who agreed to a settlement is also the largest individual plaintiff in these proceedings, representing about one third of all claims. Deutsche Bank expects that the settlement agreements concluded so far will on average consume about 45% of the total provisions which were taken in relation to the claims by plaintiffs covered by the agreements; the remaining provisions related to these specific plaintiffs will be released. Deutsche Bank anticipates that this will lead to a positive impact of approximately EUR 430M on its pre-tax profit in the third quarter. Should Deutsche Bank enter into settlement agreements with additional plaintiffs, this could result in further positive implications on the total provisions taken for the litigation. Reference Link

08:04 EDT One Stop Systems announces initial purchase order from U.S. Army - One Stop Systems announced an initial purchase order valued at over $500,000 from The U.S. Army that is expected to be recognized in 2024. The order represents a new customer, and a new platform win for OSS, which the Company believes supports a multi-year opportunity based on current program requirements. The initial order will leverage the Company's integrated hardware and storage software capabilities to support the U.S. Army's efforts to test threat detection systems, countermeasures, and other aircraft survivability systems for the U.S. Army's rotary-winged aircraft.

08:03 EDT SuperCom secures multiple new contracts in West Virginia - SuperCom announced that it has successfully secured new electronic monitoring contracts with multiple Sheriff agencies across West Virginia. These contracts leverage SuperCom's innovative PureOne suite, enhanced with both cellular and WiFi communication capabilities, to provide robust monitoring solutions in rural areas with limited cellular coverage. These newly initiated contracts are already generating recurring revenue, further solidifying SuperCom's footprint in the U.S. market, particularly in rural regions where robust and reliable monitoring solutions are crucial.

08:02 EDT Sutro Biopharma announces initiation of REFRalphaME-L1 Phase 2 trial - Sutro Biopharma announced that REFRalphaME-L1, the global Phase 2 study of luveltamab tazevibulin for patients with non-small cell lung cancer whose tumor expresses Folate Receptor-alpha, has been initiated and is open for enrollment. Initial data from this study is expected in the first half of 2025. "The initiation of REFRalphaME-L1 is an important milestone in our efforts to expand the application of luvelta to a broad range of patients with FRalpha expressing cancers. We have generated compelling preclinical evidence that luvelta can provide an important new treatment option for NSCLC, driven by its precise design, wide therapeutic window, and ability to treat patients with lower FRalpha expression profiles," said Anne Borgman, M.D., Sutro's Chief Medical Officer

08:01 EDT Stryker announces agreement to acquire Vertos Medical - Stryker announced a definitive agreement to acquire Vertos Medical Inc., a privately held company providing a minimally invasive solution for treating chronic lower back pain caused by lumbar spinal stenosis. "Allowing patients to get back to what matters most to them is what matters most to us," said Eric Wichems, Vertos Medical's Chief Executive Officer. "Stryker's mission and focus on interventional solutions provides an opportunity to further improve patients' quality of life." This transaction is subject to customary closing conditions. Stryker and Vertos Medical Inc. will continue to operate as separate entities and proceed with business as usual until the transaction closes.

07:49 EDT Charles Schwab drops 4% to $62.04 after TD sells 40.5M shares

07:38 EDT Inflection Point Acquisition Corp., USA Rare Earth enter combination agreement - USA Rare Earth and Inflection Point Acquisition Corp. II have entered into a definitive business combination agreement, which will result in USARE becoming a publicly traded company. USARE is developing a vertically integrated US REE magnet supply chain, with an early-mover advantage to become a significant ex-China producer. Founded in 2019, the Company has permanent magnet production equipment on site at its Stillwater, Oklahoma location. Phase 1 of the magnet facility is expected to be operational at the end of 2025 and will have a production capacity of up to 1,200 tpa, initially supplied by third party feedstock. The Company has plans to expand production capacity by an additional three phases for total production capacity of approximately 4,800 tpa by 2028. USARE intends to supply and scale the future of the Company's magnet production from its control of the mining rights to the Round Top Mountain deposit in West Texas through its subsidiary. Round Top is an above-ground mineral deposit containing at least 15 of the 17 rare earth elements, plus lithium and other industrial minerals. The Company has successfully piloted proprietary rare earth separation technology, and, once mining at Round Top begins, plans to deploy that technology as part of a closed-loop process for the separation of rare earth minerals. With an early mover advantage and diversified mix of target customers, USARE has a unique opportunity to become a leading domestic supplier of REE magnets and heavy REEs required for electric vehicles, green energy, and defense industries, as well as a strategic national asset for critical US industries to advance domestic growth and supply sustainability. The Proposed Business Combination implies a pro forma combined enterprise value of $870 million, excluding additional earnout consideration. This assumes an $800 million pre-money valuation of USARE, 100% rollover of USARE equity and excludes any amounts in the IPXX trust account. Existing USARE investors and investors affiliated with IPXX have agreed to a prefunded PIPE investment of ~$25 million upon the signing of the Business Combination Agreement, and we are seeking to upsize this PIPE with additional funding in connection to closing, with $9 million already committed. USARE expects to use the net proceeds from the Proposed Business Combination for general corporate purposes, including progressing the development of its Stillwater magnet facility. Under the terms of the Business Combination Agreement, USARE's existing equityholders will convert 100% of their equity ownership stakes into the combined company and are expected to own approximately 84% of the post-combination company upon consummation of the Proposed Business Combination, excluding any IPXX investors who do not choose to redeem their shares. The Proposed Business Combination is expected to be completed in early 2025, subject to customary closing conditions, including regulatory and stock approvals. The combined public company is expected to be named "USA Rare Earth, Inc." and to list its common stock and warrants to purchase common stock on Nasdaq, subject to satisfaction of Nasdaq's listing requirements. The Proposed Business Combination has been unanimously approved by the managers of USARE and the board of directors of IPXX.

07:36 EDT Walmart, Burger King announce exclusive dining benefit for Walmart+ members - Walmart+ and Burger King have joined forces to introduce an exclusive dining benefit for Walmart+ members. Starting immediately, Walmart+ members will enjoy 25% off any Burger King digital order every day. Starting in September, members can receive a free flame-grilled Whopper every three months with any purchase. Walmart+ members can easily redeem this benefit via the BK App or bk.com. To activate this benefit, Walmart+ members will need to link their membership with their existing Burger King Royal Perks account or create an account for free. Once linked, Walmart+ members can visit the offers tab on the BK app or on bk.com, select a participating Burger King location, add the desired offer to the cart and place their order.

07:32 EDT Palatin doses first patient in Phase 2 study of bremelanotide in obesity - Palatin announced that patient dosing has started for the clinical study designed to enroll up to 60 patients at four trial sites in the United States with the primary endpoint of the trial to demonstrate the safety and increased efficacy of co-administration of bremelanotide with tirzepatide on reducing body weight. Patients will undergo multiple assessments of safety and efficacy to help profile the effectiveness of bremelanotide in treating general obesity as a stand-alone treatment or in conjunction with GLP-1/GIP therapy. Full patient enrollment in this Phase 2 clinical study of BMT-801 is currently expected in Q3 with topline data readout expected in the first half of calendar year 2025.

07:24 EDT Bayer commences ALPINE-1 study - Bayer announced the start of ALPINE-1 study, a Phase II clinical trial with BAY3283142, an investigational soluble guanylate cyclase activator, in patients with chronic kidney disease. The results of this study have the potential to provide evidence of the sGC activator as a viable treatment option for cardiovascular diseases.

07:19 EDT Enthusiast Gaming teams up with State Farm - Enthusiast Gaming announced that it has teamed up with State Farm. Enthusiast's esports team, Luminosity, will be hosting online watch parties to promote the State Farm Gamerhood: Neo City on Twitch every Friday in August at 6pm ET. State Farm has tapped Luminosity Gaming content creators to promote and host watch parties of episodes of Gamerhood throughout the month of August, driving increased viewership and engagement. Enthusiast Gaming is proud to team up with the State Farm Gamerhood campaign for a third consecutive year.

07:17 EDT Brink's announces Teteak as Brinks Business System leader - The Brink's Company (BCO) announced that Joshua Teteak will be appointed executive vice president, Brink's Business System, effective August 26. Teteak will succeed Jamal Powell who has been appointed executive vice president and vice president, Brink's Global Services for the United States. Teteak will join the executive leadership team and report to Mark Eubanks, president and chief executive officer. Teteak will join Brink's from GE Healthcare (GEHC) where he served as global head of integrated supply chain.

07:13 EDT Tilray announces release of premium cannabis brand - Tilray Brands announced the release of premium cannabis brand, BROKEN COAST's latest small batch flower strain, 'Milk & Cookies', joining the brand's renowned craft cannabis portfolio of Cherry Cheesecake, EmergenZ, Sour OG, Holy Grail Kush, and Amnesia Haze.

07:12 EDT Nexstar announces select television stations to become affiliates of CW Network - Nexstar announced that its owned and operated television stations in Augusta, Georgia; Monroe, Louisiana; Wichita Falls, Texas; Terre Haute, Indiana; and Utica, New York, will become affiliates of The CW Network. All five local stations will begin carrying the network's primetime entertainment, live sports, and special event programming beginning in September and October. The CW is available in 100% of U.S. households, delivering primetime entertainment programming and 500 hours per year of sports programming. The free, ad-supported CW App is widely available on all major platforms. The CW App is home to The CW's primetime programming, live streaming of LIV Golf tournaments, and a library of entertaining film and television content.

07:07 EDT Alkermes initiates Vibrance-2 Phase 2 study evaluating ALKS 2680 - Alkermes announced initiation of the Vibrance-2 study, a phase 2 clinical trial evaluating the safety and efficacy of ALKS 2680 compared to placebo in adults with narcolepsy type 2. ALKS 2680 is the company's novel, investigational, oral, selective orexin 2 receptor agonist in development as a once-daily treatment for narcolepsy, a chronic, neurological disorder characterized by excessive daytime sleepiness. The study is expected to enroll approximately 80 patients with NT2 across sites in the U.S., Australia and Europe.

07:05 EDT Skye Bioscience launches Phase 2 CBeyond trial of nimacimab - Skye Bioscience has started screening patients for a Phase 2 clinical trial of its novel peripheral CB1 inhibitor, nimacimab, a negative allosteric modulating antibody. The study will assess the ability of nimacimab as a next-generation weight loss therapeutic to safely and effectively reduce weight in patients with obesity. "There is clearly a need for alternative mechanisms of action that can provide physicians and patients with improved overall health outcomes in the pursuit of weight loss beyond those achieved with GLP-1 and GIP drugs. We believe that peripheral CB1 inhibition, and nimacimab, a unique biologic drug within the class, have attributes that may help provide such outcomes, and we look forward to our goals of reporting interim data from this Phase 2 obesity trial in Q2 of 2025 and final data in Q4 of 2025," said Punit Dhillon, Chief Executive Officer of Skye. "CB1 inhibition research has shown its potential to directly promote energy expenditure and fat breakdown1, improve leptin sensitivity, and peripherally modulate hunger and satiety 3. We are pleased to be assessing nimacimab as a monotherapy but to also undertake a preliminary evaluation of our peripheral CB1 inhibitor in combination with a GLP-1 drug."

06:52 EDT Rafael Holdings, Cyclo Therapeutics enter merger agreement - Rafael Holdings (RFL), and Cyclo Therapeutics (CYTH) announced that they have entered into a definitive merger agreement to combine the two companies to focus on the development of Trappsol Cyclo for the treatment of Niemann-Pick Disease Type C1. On consummation of the merger, Rafael Holdings will issue shares of its Class B common stock to Cyclo Therapeutics' shareholders, based on an exchange ratio valuing Cyclo Therapeutics shares at $.95 per share and Rafael Holdings at its cash value combined with the value of its marketable securities and certain other investments less certain current liabilities. In addition, the cash value will take into account the funding of Cyclo's operations by Rafael with convertible notes through closing. Following the closing, Rafael Holdings intends to fund the TransportNPC clinical trial to its 48-week interim analysis. The boards of directors of Rafael Holdings and Cyclo Therapeutics have approved this transaction and expect it to close in late 2024, pending approval of the companies' shareholders, the effectiveness of a registration statement to register the shares of Class B common stock of Rafael Holdings to be issued in the transaction and other customary closing conditions.

06:43 EDT BetMGM launches single digital wallet in Nevada - BetMGM has become the first sports betting app to offer Nevada bettors connectivity through a single, digital wallet. Through its operation and partnership with MGM Resorts (MGM) and powered by Entain's (GMVHF) technology, this feature makes BetMGM the only legalized sports betting app to allow Nevada residents and visitors to wager in the state and carry their funds to BetMGM mobile markets nationwide. The company said, "The convenience of BetMGM's single account and wallet feature allows the user to sign up once in- person at an MGM Resorts property in Nevada and then enjoy the enhanced sports betting app across all U.S. BetMGM mobile markets. New Nevada customers can sign up by downloading the mobile app, completing the verification steps, and visiting one of BetMGM's nine retail sportsbooks including Bellagio, ARIA, The Cosmopolitan of Las Vegas, MGM Grand, Park MGM, Mandalay Bay, New York-New York, Luxor or Excalibur to complete their registration. When traveling to another jurisdiction, users will receive a pop-up message upon opening the app allowing them to switch to their account within the BetMGM market where they are currently located. Customers also can manually select their market within the app's account tab to view their account for that state. In February, BetMGM introduced a newly designed mobile sports betting app in Nevada that features an increased variety of Entain's Angstrom-powered prop and parlay offerings along with digital deposits and withdrawals. Several new product enhancements also are expected to elevate the BetMGM experience for the start of the 2024 professional football season. New Nevada customers can download the BetMGM app and receive a first bet offer of up to $250 paid back in bonus bets (offer only available in Nevada). Bonus bets are non-withdrawable and expire in seven (7) days. Existing users can check the promotions tab in their app for incentives such as parlay boost tokens, odds boosts and other available offers. Players also can earn BetMGM Rewards Points and Tier Credits by playing on BetMGM Sportsbook which are redeemable for digital bonuses and MGM Rewards Points."

06:33 EDT Babcock & Wilcox awarded $8M contract for U.K. renewable energy project - Babcock & Wilcox's B&W Environmental business segment has been awarded a contract for more than $8M to design and supply a cooling system for a U.K. renewable energy facility. B&W Environmental will supply a SPIG air-cooled condenser for the plant, which will generate low-carbon baseload electricity.

06:21 EDT Stellantis announces plans for Belvidere plant will be delayed - The Company confirms it has notified the UAW that plans for Belvidere will be delayed, but firmly stands by its commitment. As always, the Company is committed to engaging with the Union on a productive, respectful and forward-looking dialogue. The Company has not violated the commitments made in the Investment Letter included in the 2023 UAW Collective Bargaining Agreement and strongly objects to the Union's accusations. In fact, the UAW agreed to language that expressly allows the Company to modify product investments and employment levels. Therefore, the Union cannot legally strike over a violation of this letter at this time.

06:06 EDT OS Therapies clarifies CUSIP of common stock - OS Therapies provided a clarification for market participants, specifically brokerage firms, regarding the CUSIP identifier of the company's common stock. The company's common stock began trading on the NYSE American on August 1st under CUSIP 68764Y108 - Old CUSIP -. On August 5th, the company completed certain matters related to a corporate action prior to the listing of its common stock on the NYSE American that resulted in new CUSIP 68764Y207 being assigned to the company's common stock. All shares sold or purchased under the Old CUSIP are now identified as the same number of shares under the New CUSIP. Shares of the company's common stock listed under the Old CUSIP should be identified, sold and purchased under the new CUSIP 68764Y207.

06:04 EDT Liquidia challenges FDA decision on Yutrepia exclusivity - Liquidia has filed litigation in the U.S. District Court of the District of Columbia that challenges the recent decision by the FDA to grant 3-year new clinical investigation exclusivity to Tyvaso DPI. FDA granted tentative approval of Yutrepia inhalation powder to treat pulmonary arterial hypertension, or PAH, and pulmonary hypertension associated with interstitial lung disease, or PH-ILD, patients on August 16. As a result of the FDA's award of NCI exclusivity to Tyvaso DPI, the final approval of Yutrepia inhalation powder is currently delayed until after the expiration of the exclusivity on May 23, 2025. NCI exclusivity is only granted for a period of three years from the date of an FDA approval that is supported by certain types of clinical studies, expressly excluding bioavailability studies and clinical investigations that a drug sponsor has previously submitted to FDA. Separately, on August 20, United Therapeutics voluntarily dismissed the complaint it had filed against the FDA challenging the FDA's acceptance of Liquidia's amended NDA for Yutrepia for review. With the FDA's grant of tentative approval for Yutrepia , the FDA decided that it was proper for Liquidia to add PH-ILD to the NDA for Yutrepia via an amendment. Liquidia is seeking final approval of Yutrepia as soon as possible.

05:35 EDT Amazon Web Services launches AWS Asia Pacific Region in Malaysia - Amazon Web Services, or AWS, an Amazon company announced the launch of the AWS Asia Pacific Region. Developers, startups, entrepreneurs, and enterprises, as well as government, education, and nonprofit organizations, will have greater choice for running their applications and serving end users from AWS data centers located in Malaysia. As part of its long-term commitment, AWS is planning to invest an estimated $6.2B in Malaysia through 2038.

05:29 EDT Canadian National moves forward with lockout of TCRC employees - Canadian National has formally locked out employees represented by the Teamsters Canada Rail Conference, or TCRC, as of August 22 at after the union did not respond to another offer by CN in a final attempt to avoid a labor disruption. The company said, "This offer improved wages and would have seen employees work less days in a month by aligning hours of service in the collective agreement with federally mandated rest provisions. The offer also proposed a pilot project for hourly rates and scheduled shifts on a portion of the network as CN continues to believe this is a better and more predictable framework for our employees. Without an agreement or binding arbitration, CN had no choice but to finalize a safe and orderly shutdown and proceed with a lockout. Over the last nine months, CN has negotiated in good faith. The Company consistently proposed serious offers, with better pay, improved rest, and more predictable schedules. The Teamsters have not shown any urgency or desire to reach a deal that is good for employees, the company and the economy. We urge the Teamsters to engage in these negotiations with the urgency and importance that this situation requires."

05:20 EDT Corpay becomes official foreign exchange partner of Manchester City - Corpay announced that Corpay's Cross-Border business has entered into an agreement with the current Premier League title holder, Manchester City to become their official foreign exchange partner. As part of this partnership, Corpay Cross-Border has also been named an official partner of Manchester City Women.